2 completed, 1 recruiting. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 2, Recruiting 1 |
Follow NOAC: new trials by email Literature Review of NOAC trials Research Report on NOAC
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Single-stage Pulmonary Vein Isolation Combined With Percutaneous Left Atrial Appendage Occluder Implantation in Patients With Recent Onset Ischemic Stroke and Atrial Fibrillation PVI + LAAO, single stage, LAAO, NOAC - Ischemic Stroke, Atrial Fibrillation | Phase 4 | Recruiting | Medical University of Silesia | 240 | 2025-10-31 | 2026-04-13 |
| Anticoagulant Versus Dual Antiplatelet Therapy for Preventing Leaflet Thrombosis and Cerebral Embolization After Transcatheter Aortic Valve Replacement NOAC, DAPT - Aortic Valve Stenosis | Phase 4 | Completed | Duk-Woo Park, MD | 235 | 2018-03-15 | 2021-11-08 |
| Left Atrial Appendage Closure vs. Novel Anticoagulation Agents in Atrial Fibrillation NOAC, Left atrial appendage closure - Atrial Fibrillation | Phase 4 | Completed | Charles University, Czech Republic | 400 | 2015-10-13 | 2021-06-11 |
Atrial Fibrillation (2) · Aortic Valve Stenosis (1) · Ischemic Stroke (1) · Stroke (1)
Charles University, Czech Republic (1) · Duk-Woo Park, MD (1) · Medical University of Silesia (1)
Czechia (1) · Hong Kong (1) · Poland (1) · South Korea (1) · Taiwan (1)
Maciej T. Wybraniec, MD, PhD, Professor (1) · Seung-jung Park, MD (1)
PMID 10753982, PMID 15313941, PMID 15842354, PMID 16765759, PMID 19683639, PMID 19717844, PMID 21309657, PMID 21830957, PMID 21870978, PMID 22497820, PMID 23273528, PMID 23325525, PMID 23500276, PMID 23583249, PMID 23973952, PMID 32586585, PMID 33402409, PMID 34748929, PMID 35373583, PMID 37586823, PMID 38151311, PMID 40816554, PMID 41357284, PMID 7829800, PMID 8721656, PMID 9809895